Drug Trial Radar · NCT07515872
Long Duration High Frequency Ultrasound for the Treatment of Osteoarthritis
Last checked: Nov 20, 2026Latest source record: Apr 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
240
Planned (sponsor's estimate)
Start
May 1, 2026
Primary completion
May 31, 2027
Study completion May 31, 2028
Sponsor
- Lead sponsor
- ZetrOZ, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 7, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 65 years, up to 85 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the ability of long-duration high-frequency continuous-wave therapeutic ultrasound to alleviate knee Osteoarthritis pain over an 12-week period. The primary objective of this study is to evaluate the analgesic effect of ultrasound treatment in subjects suffering from knee Osteoarthritis pain. Secondary objectives are to assess the ability of ultrasound treatment to improve joint function.
Conditions
- Arthritis
- Osteo Arthritis of the Knee
Interventions
Sustained Acoustic Device with 2.5% Diclofenac PatchDevice
Patients apply the SAM Ultrasonic Diathermy Device daily for 1-4 hours of continuous therapeutic ultrasound at 3 megahertz(MHz) frequency and 0.132 Watts/cm\^2 with 2.5% Diclofenac patches.
Sustained Acoustic Device with 0% Diclofenac PatchDevice
Patients apply the SAM Ultrasonic Diathermy Device daily for 1-4 hours with 0% diclofenac patches.
Intra articular injectionDrug
Single intraarticular injection of 1cc 40mg/cc triamcinolone acetonide
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Pain Units on a Scale (0-10) 0 Being Least, 10 Being Worst Pain From BaselineTime frame: Through study completion, average of 12 weeks
- Change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)Time frame: Through study completion, average of 12 weeks.
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Orthopaedic Foundation
Stamford, Connecticut
Cayuga Medical Center - Medical Pain Consultants
Dryden, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.